Skip to Content



PDF options:  View Fullscreen   Download PDF

PDF Transcript

Zanipress 20 mg/20 mg film-coated tablets
Enalapril maleate/Lercanidipine hydrochloride

Read all of this leaflet carefully before you start taking this medicine because it contains
important information for you.
Keep this leaflet. You may need to read it again.
If you have any further questions, ask your doctor or pharmacist.
This medicine has been prescribed for you only. Do not pass it on to others. It may harm them,
even if their signs of illness are the same as yours.
If you get any side effects, talk to your doctor or pharmacist. This includes any possible side
effects not listed in this leaflet.

What is in this leaflet:

What Zanipress is and what it is used for
What you need to know before you take Zanipress
How to take Zanipress
Possible side effects
How to store Zanipress
Contents of the pack and other information


What Zanipress is and what it is used for

Zanipress is a fixed combination of an ACE-inhibitor (enalapril maleate) and a calcium channel
blocker (lercanidipine hydrochloride), two medicines that lower blood pressure.
Zanipress is used to treat high blood pressure (hypertension) in adult patients who are currently taking
enalapril and lercanidipine as separate tablets.

What you need to know before you take Zanipress

Do not take Zanipress:
• if you are allergic to enalapril or lercanidipine or any of the other ingredients of this medicine
(listed in Section 6).
• If you have ever had an allergic reaction to a type of medicine similar to those contained in
Zanipress, i.e. medicines called ACE-inhibitors or calcium channel blockers.
• If you have ever had swelling of your face, lips, mouth, tongue or throat which caused difficulty in
swallowing or breathing (angioedema) after taking a type of medicine called ACE-inhibitors, or
when the reason why was not known or it was inherited.
• If you have diabetes or kidney problems and are taking a medicine containing aliskiren to reduce
blood pressure.
• If you are more than 3 months pregnant (it is also better to avoid Zanipress in early pregnancy – see
Pregnancy section).
• If you suffer from certain heart diseases:
• obstruction to the flow of blood out of the heart, including a narrowing of the aortic valve in
your heart
• untreated heart failure

• chest discomfort occurring at rest or becoming worse or happening more often (unstable
• within one month of a heart attack.
If you have severe kidney problems, or if you are undergoing dialysis.
If you have severe liver problems
If you are taking drugs that are inhibitors of the hepatic metabolism, such as:
• antifungals (e.g. ketoconazole, itraconazole).
• macrolide antibiotics (e.g. erythromycin, troleandomycin).
• antivirals (e.g. ritonavir).
If you are taking another drug called cyclosporin or ciclosporin (used after transplants to prevent
organ rejection).
With grapefruit or grapefruit juice.

Warning and precautions
Talk to your doctor or pharmacist before taking Zanipress:
• If you have low blood pressure (you may notice this as faintness or dizziness, especially when
• If you have been very sick (excessive vomiting) or had had diarrhoea recently.
• If you are on a salt restricted diet.
• If you have a heart problem.
• If you have a condition involving the blood vessels in the brain.
• If you have a kidney problem (including kidney transplantation).
• If you have a liver problem.
• If you have a blood problem, such as low or lack of white blood cells (leucopenia,
agranulocytosis), low platelet count (thrombocytopenia or a decreased number of red blood cells
• If you have a collagen vascular disease (e.g. lupus erithematosus, rheumatoid arthritis or
• If you are a black patient you should be aware that black patients are at increased risk of allergic
reactions with swelling of the face, lips, tongue or throat with difficulty in swallowing or breathing
when taking ACE-inhibitors.
• If you have diabetes.
• If you develop a persistent dry cough.
• If you are taking potassium supplements, potassium-sparing agents, or potassium-containing salt
• If you have an intolerance to certain sugars (lactose)
If you are about to have a procedure
If you are about to have any of the following, tell your doctor that you are taking Zanipress:
• any surgery or receive anaesthetics (even at the dentist)
• a treatment to remove cholesterol from your blood called “LDL apheresis”
• a desensitization treatment, to lower the effect of any allergy to bee or wasp stings.
You must tell your doctor if you think you are (or might become) pregnant or breast-feeding (see
pregnancy, breast-feeding and fertility section).
Children and adolescents
Do not give this medicine to children and adolescents under the age of 18 years as there is no
information on if it works and if it is safe.
Other medicines and Zanipress
Zanipress must not be taken with certain medications.

Tell your doctor or pharmacist if you are taking, have recently taken or might take any other
medicines, including medicines obtained without prescription. This is because when Zanipress is taken
with certain other medicines, the effect of Zanipress or of the other medicine may be changed, or
certain side effects may occur more frequently.
In particular, tell your doctor or pharmacist if you are taking any of the following medicines:
• medicines containing potassium (including dietary salt substitutes)
• other medicines that lower blood pressure, such as angiotensin-receptor-blockers, diuretics (water
pills), or a medicine called aliskiren
• lithium (a medicine used to treat a certain kind of depression)
• medicines for depression called ‘tricyclic antidepressants’
• medicines for mental problems called ‘antipsychotics’
• non-steroidal anti-inflammatory drugs, including COX-2-inhibitors (medicines that reduce
inflammation and can be used to help relieve pain)
• certain pain or arthritis medicines including gold therapy
• certain cough and cold medicines and weight reducing medicines which contain something called a
‘sympathomimetic agent’
• medicines for diabetes (including oral antidiabetic medicines and insulin) astemizole or terfenadine
(medicines for allergies)
• amiodarone or quinidine (medicines to treat a fast heart beat)
• phenytoin or carbamazepine (medicines for epilepsy)
• rifampicin (a drug for the treatment of tuberculosis)
• digoxin (a medicine to treat heart problems)
• midazolam (a medicine that helps you to sleep)
• beta-blockers (medicines to treat high blood pressure and heart problems)
• a medicine for ulcers and heartburn called cimetidine at daily doses of more than 800 mg
Zanipress with food, drink and alcohol
• Zanipress should be taken at least 15 minutes before a meal.
• Alcohol can increase the effect of Zanipress. You are therefore advised either to consume no
alcohol or to strictly limit your alcohol intake.
• Zanipress should not be taken with grapefruit or grapefruit juice.
Pregnancy, breast-feeding and fertility
Pregnancy and fertility
You must tell your doctor if you think you are (or might become) pregnant. Zanipress is not
recommended in women who might become pregnant and in early pregnancy and must not be taken
when you are more than 3 months pregnant, as it may cause serious harm to your baby if used after the
third month of pregnancy.
Tell your doctor if you are breast-feeding or about to start breast-feeding. Breastfeeding newborn
babies (first few weeks after birth), and especially premature babies, is not recommended whilst taking
Zanipress. In the case of an older baby your doctor should advise you on the benefits and risks of
taking Zanipress whilst breast-feeding, compared with other treatments.
Driving and using machines
If you develop dizziness, weakness, tiredness or drowsiness during treatment with this medicine, you
must not drive a vehicle or operate machines.
Zanipress contains lactose
If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor
before taking this medicinal product.


How to take Zanipress

Always take this medicine exactly as your doctor has told you. Check with your doctor or pharmacist
if you are not sure.
Adults: unless otherwise prescribed by your doctor, the recommended dose is one tablet once daily at
the same time each day. The tablet should preferably be taken in the morning at least 15 minutes
before breakfast. The tablets should be swallowed whole with water.
Patients with kidney problems/elderly: your dose of medicine will be decided by your doctor
and will be based on how well your kidneys are working.
If you take more Zanipress than you should
If you have taken more Zanipress than you should, talk to your doctor or go to the hospital straight
away. Take the medicine pack with you. Taking more than the correct dose can cause an excessive
drop in blood pressure and your heart can beat irregularly or faster.
If you forget to take Zanipress
• If you forget to take your tablet, skip the missed dose.
• Take the next dose as usual.
• Do not take a double dose to make up for the forgotten dose.
If you stop taking Zanipress
• Do not stop taking your medicine unless your doctor tells you to.
• If you have any further questions on the use of this medicine, ask your doctor or pharmacist.


Possible side effects

Like all medicines, Zanipress can cause side effects, although not everybody gets them. The following
side effects may happen with this medicine:
Some side effects can be serious.
If any of the following happen, tell your doctor straight away:
• Allergic reaction with swelling of your face, lips, tongue or throat which may cause difficulty in
breathing or swallowing;
When you start taking Zanipress you might feel faint or dizzy or have blurred vision; this is caused by
a sudden fall in blood pressure and if this happens, it will help to lie down. If you are worried, please
talk to your doctor.
Side effects observed with Zanipress
Common (may affect up to 1 in 10 people)
Cough, feeling dizzy, headache.
Uncommon (may affect up to 1 in 100 people)
Changes in blood values such as a lower number of blood platelets, increased blood potassium level,
nervousness (anxiety), feeling dizzy when standing up, vertigo, fast heartbeat, fast or uneven heartbeat
(palpitations), sudden reddening of your face, neck or upper chest (flushing), low blood pressure,
abdominal pain, constipation, feeling sick (nausea), higher levels of liver enzymes, redness of the skin,
joint pain, increased number of times one urinates, feeling weak, tiredness, feeling hot, ankle swelling.

Rare (may affect up to 1in 1,000 people)
Anaemia, allergic reactions, ringing in your ears (tinnitus), fainting, dry throat, sore throat, indigestion,
salty sensation on the tongue, diarrhoea, dry mouth, swelling of gums, allergic reaction with swelling
of the face, lips, tongue or throat with difficulty in swallowing or breathing, skin rash, hives, getting
up at night to urinate, producing large amounts of urine, impotence.
Additional side effects observed with enalapril or lercanidipine alone
Very Common (affects more than 1 in 10 people)
Blurred vision.
Common (affects less than 1 in 10 people)
depression, chest pain, changes in heart rhythm, angina, shortness of breath, change in sense of taste,
increased levels of creatinine in your blood (usually detected by a test).
Uncommon (affects less than 1 in 100 people)
Anaemia (including aplastic and haemolytic), sudden fall in blood pressure, confusion, sleeplessness
or sleepiness, feeling your skin prickling or being numb, heart attack (possibly due to very low blood
pressure in certain high-risk patients, including those with blood flow problems of the heart or brain),
stroke (possibly due to very low blood pressure in high-risk patients), runny nose, sore throat and
hoarseness, asthma, slow movement of food through your intestine, inflammation of your pancreas,
being sick, irritated stomach (gastric irritations), ulcer, anorexia, increased perspiration, itching or
nettle rash, loss of hair, impaired kidney function, kidney failure, high level of proteins in your urine
(measured in a test), muscle cramps, generally feeling unwell (malaise), high temperature (fever), low
level of blood sugar or sodium, high level of blood urea (all measured in a blood test).
Rare (affects less than 1 in 1,000 people)
Changes in blood values such as a lower number of white blood cells, bone marrow depression,
autoimmune diseases, strange dreams or sleep problems, ‘Raynaud’s phenomenon’ (where your hands
and feet may become very cold and white due to low blood flow), pulmonary infiltrates, inflammation
of your nose, pneumonia, liver problems such as lower liver function, inflammation of your liver,
jaundice (yellowing of the skin or eyes), higher levels of bilirubin (measured in a blood test), erythema
multiforme (red spots of different shapes on the skin), Stevens-Johnson syndrome (a serious skin
condition where you have reddening and scaling of your skin, blistering or raw sores, or detachment of
the top layer of skin from bottom layers), lower amount of urine produced, enlargement of the
mammary glands in males.
Very Rare (affects less than 1 in 10,000 people)
Swelling in your intestine (intestinal angioedema).
Rare (affects less than 1 in 1,000 people)
Angina pectoris (chest pain due to lack of blood to your heart), vomiting, heartburn, muscle pain.
Very Rare (affects less than 1 in 10,000 people)
Chest pain.
Patients with pre-existing angina pectoris may experience increased frequency, duration or severity of
the attacks with the group of medicines to which lercanidipine belongs. Isolated cases of heart attack
may be observed.

If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please
tell your doctor or pharmacist. You can ask your doctor or pharmacist for more information about side
effects. Both have a more complete list of side effects.
Reporting of suspected adverse reactions
If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects
not listed in this leaflet. You can also report side effects directly via the national reporting system
listed in Appendix V*. By reporting side effects you can help provide more information on the safety
of this medicine.

How to store Zanipress

Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the blister and the carton after EXP.
The expiry date refers to the last day of that month.
Store in the original package in order to protect from light and moisture. Do not store above 25°C.
Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to
throw away medicines you no longer use. These measures will help protect the environment.


Contents of the pack and other information

What Zanipress contains
The active substances are enalapril maleate and lercanidipine hydrochloride.
Each film-coated tablet contains: 20 mg enalapril maleate (equivalent to 15.29 mg enalapril) and 20
mg lercanidipine hydrochloride (equivalent to 18.88 mg lercanidipine).
The other ingredients are:
Core: lactose monohydrate, microcrystalline cellulose, sodium starch glycolate, povidone K30, sodium
hydrogen carbonate, magnesium stearate.
Film-coating: hypromellose, titanium dioxide (E171), macrogol 6000, Iron oxide yellow (E172), talc,
Iron oxide red (E172).
What Zanipress looks like and contents of the pack
Zanipress 20 mg/20 mg tablets are orange, circular and biconvex tablets of 12 mm.
Zanipress 20 mg/20 mg is available in packs of 7, 14, 28, 30, 35, 42, 50, 56, 90, 98 and 100 tablets.
Not all pack sizes may be marketed.
Marketing Authorisation Holder and Manufacturer
Marketing Authorization Holder:
RECORDATI Industria Chimica e Farmaceutica S.p.A. – Via Matteo Civitali 1 – 20148 Milan, Italy
RECORDATI Industria Chimica e Farmaceutica S.p.A. – Via Matteo Civitali 1 – 20148 Milan, Italy
This medicinal product is authorised in the Member States of the EEA under the following

Zanipril 20 mg/20 mg Filmtabletten
Lercaprel 20 mg/20 mg potahované tablet
Lercaprel 20 mg/20 mg plėvele dengtos tabletės
Lercaril 20mg/20mg comprimate filmate
Lercaprel 20 mg/20 mg filmsko obložene tablete

This leaflet was last approved in (MM/YYYY)

Belgium, Luxemburg
Cyprus, United Kingdom
Czech Rep.
Denmark, Finland, Iceland, Malta,
Norway, Portugal, Spain, Germany
Greece, Latvia, Poland, Slovak Rep.
Ireland, Estonia
The Netherlands

+ Expand Transcript

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.